fluorobenzenes has been researched along with Hyperlipoproteinemia Type IV in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anzenbacher, P; Anzenbacherová, E; Matuskova, Z; Siller, M; Skottová, N; Vecera, R; Zacharová, A | 1 |
1 other study(ies) available for fluorobenzenes and Hyperlipoproteinemia Type IV
Article | Year |
---|---|
The influence of rosuvastatin on liver microsomal CYP2C6 in hereditary hypertriglyceridemic rat.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cholesterol, Dietary; Cytochrome P-450 CYP2C9; Cytochrome P450 Family 2; Fluorobenzenes; Gene Expression Regulation, Enzymologic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type IV; Male; Microsomes, Liver; Pyrimidines; Rats; Rats, Mutant Strains; Rats, Wistar; RNA, Messenger; Rosuvastatin Calcium; Steroid 21-Hydroxylase; Sulfonamides; Transcription, Genetic | 2012 |